Ambrosia Biosciences Raises $100M for GLP-1 Pipeline
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
MUMBAI, INDIA, March 21, 2026 Sun Pharmaceutical Industries Limited has announced the launch of its semaglutide injection under the...
MILWAUKEE, Feb. 15, 2026 — New research presented by the American Academy of Allergy, Asthma & Immunology (AAAAI) reveals...
BEIJING, December 2025 — New Phase 1b clinical data show that mazdutide, an investigational metabolic therapy, delivered significant weight-loss...
NEW YORK, NY — November 14, 2025 — Pfizer announced it has completed its acquisition of Metsera, Inc., strengthening...
Boston, November 10, 2025 — Rhythm Pharmaceuticals, Inc. has announced the presentation of four pivotal datasets at ObesityWeek® 2025,...
INDIANAPOLIS, Oct. 15, 2025 — Eli Lilly and Company (NYSE: LLY) announced positive topline results from two pivotal Phase...
